Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Heart Failure

Mark D Huffman, Greg A Roth, Karen Sliwa, Clyde W Yancy, Dorairaj Prabhakaran
Dorairaj Prabhakaran, Shuchi Anand, Thomas A Gaziano, Jean-Claude Mbanya, Yangfeng Wu, Rachel Nugent
, editors.
In: Cardiovascular, Respiratory, and Related Disorders. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 17. Chapter 10.
Review

Heart Failure

Mark D Huffman et al.

Excerpt

This chapter presents data on the efficacy, effectiveness, and cost-effectiveness of priority heart failure–related interventions. Heart failure is a clinical syndrome in which the heart is unable to meet the metabolic demands of the body because of functional limitations in ventricular filling (diastole), ejection (systole), or both (Yancy and others 2013). Heart failure is a heterogeneous, progressive, chronic disease with protean symptoms, including fatigue; breathlessness at rest or with exertion; and fluid retention in the lungs, abdomen, or extremities. The stages and functional classes of heart failure are detailed in box 10.1.

PubMed Disclaimer

References

    1. Alefan Q, Ibrahim M I M, Razak T A, Ayub A. 2009. “Cost-Effectiveness of Antihypertensive Treatment in Malaysia.” Malaysian Journal of Pharmaceutical Sciences 7 (2): 137–52.
    1. Bertoldi E G, Rohde L E, Zimerman L I, Pimentel M, Polanczyk C A. 2013. “Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Heart Failure: The Perspective of a Middle-Income Country’s Public Health System.” International Journal of Cardiology 163 (3): 309–15. ISSN 0167–5273. - PubMed
    1. Butler J R, Fletcher P J. 1996. “A Cost-Effectiveness Analysis of Enalapril Maleate in the Management of Congestive Heart Failure in Australia.” Australian and New Zealand Journal of Medicine 26 (1): 89–95. - PubMed
    1. Callender T, Woodward M, Roth G, Farzadfar F, Lemarie J C, and others. 2014. “Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.” PLoS Medicine 11 (8): e1001699. doi:10.1371/journal.pmed.1001699. - PMC - PubMed
    1. Chatterjee S, Biondi-Zoccai G, Abbate A, D’Ascenzo F, Castagno D, and others. 2013. “Benefits of Beta Blockers in Patients with Heart Failure and Reduced Ejection Fraction: Network Meta-Analysis.” BMJ 346 (1): f55–55. doi:10.1136/bmj.f55. - PMC - PubMed